NexImmune's Debt Round

NexImmune raised a round of funding on December 27, 2013.

NexImmune is an early stage biopharmaceutical company developing immuno-therapeutics based on the Artificial IMmune (AIM) technology. The AIM technology provides an important advance in the developmen…

Articles about NexImmune's Debt Round: